Omalizumab and dupilumab for the treatment of autosomal-recessive DOCK8 hyper-IgE syndrome

Indian J Dermatol Venereol Leprol. 2025 Jan-Feb;91(1):94-96. doi: 10.25259/IJDVL_348_2023.
No abstract available

Publication types

  • Letter